CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 81.9% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Amgen AMGN

Amgen live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Oct 26, 23:24

Does Amgen (AMGN) Have Enough Cash Flow To Justify Its Price?

Amgen Inc
Webhose 2026 Oct 26, 23:00

Amgen names David Gibbs to board of directors

Amgen Inc
Webhose 2026 Oct 26, 21:52

AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS | Morningstar

Amgen Inc
Webhose 2026 Oct 26, 16:05

Best Biotech Stocks Worth Watching - October 26th - Markets Daily

Amgen Inc
Webhose 2026 Oct 26, 15:58

ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data

Amgen Inc
Webhose 2026 Oct 26, 10:09

4,797 Amgen Inc. $AMGN Shares Purchased by Sigma Planning Corp - Zolmax

Amgen Inc
Webhose 2026 Oct 26, 10:08

Amgen Inc. $AMGN Stock Position Raised by Sigma Planning Corp

Amgen Inc
Webhose 2026 Oct 26, 08:17

2,418 Shares of Amgen Inc. $AMGN Bought by IRON Financial LLC

Amgen Inc
Webhose 2026 Oct 26, 08:07

Roche Drug Beats Amgen, Bristol Rivals in Lung Cancer Study (1)

Amgen Inc
Webhose 2026 Oct 26, 02:25

Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)

Amgen Inc
Webhose 2026 Oct 26, 01:20

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Ascendis Pharma (ASND) and Amgen (AMGN)

Amgen Inc
Webhose 2026 Oct 25, 22:15

Amgen announces Phase 3 results of Imdelltra with AstraZeneca's Imfinzi

Amgen Inc
Webhose 2026 Oct 25, 20:55

AstraZeneca announces results from DeLLphi-305 trial of IMFINZI

Amgen Inc
Webhose 2026 Oct 25, 11:36

Teva (TEVA) Gets a Buy from Piper Sandler

Amgen Inc
Webhose 2026 Oct 25, 08:49

1,429 Amgen Inc. $AMGN Shares Sold by Citizens Financial Group Inc. RI - Markets Daily

Amgen Inc
Webhose 2026 Oct 25, 07:04

Amgen Inc. $AMGN Stake Lessened by Atlas Private Wealth Advisors

Amgen Inc
Webhose 2026 Oct 24, 23:02

Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study

Amgen Inc
Webhose 2026 Oct 24, 16:35

New Amgen drug combination shows survival gains in lung cancer trial

Amgen Inc
Webhose 2026 Oct 24, 16:14

Amgen-AstraZeneca drug combination cut risk of death in small cell lung cancer by 58%

Amgen Inc
Webhose 2026 Oct 24, 14:40

Sterling Capital Management LLC Purchases 22,485 Shares of Amgen Inc. $AMGN

Amgen Inc
Webhose 2026 Oct 24, 14:34

Amgen Reports Combo Cuts Lung Cancer Death Risk 58%

Amgen Inc
Webhose 2026 Oct 24, 13:36

NBT Bank N.A. Acquires New Shares in Amgen Inc. $AMGN

Amgen Inc
Webhose 2026 Oct 24, 11:47

Vision Financial Markets LLC Makes New Investment in Amgen Inc. $AMGN - Stock Observer

Amgen Inc
Webhose 2026 Oct 23, 19:15

AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?

Amgen Inc
Webhose 2026 Oct 23, 17:45

Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different

Amgen Inc
Webhose 2026 Oct 23, 08:08

14,670 Amgen Inc. $AMGN Shares Sold by Investment House LLC

Amgen Inc
Webhose 2026 Oct 23, 07:13

Amgen Inc. $AMGN Shares Purchased by Brookstone Capital Management

Amgen Inc
Webhose 2026 Oct 23, 07:12

Amgen Inc. $AMGN Shares Sold by Axxcess Wealth Management LLC

Amgen Inc
Webhose 2026 Oct 23, 05:29

Amgen Inc. (NASDAQ:AMGN) Stock Has Consensus Price Target of $387.93 According to Analysts - Stock Observer

Amgen Inc
Webhose 2026 Oct 23, 01:45

Amgen Inc. $AMGN Shares Sold by Investment House LLC - Daily Political

Amgen Inc
Webhose 2026 Oct 23, 00:00

Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial

Amgen Inc
Webhose 2026 Oct 23, 00:00

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

Amgen Inc
Webhose 2026 Oct 22, 21:22

Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy? - Markets Daily

Amgen Inc
Webhose 2026 Oct 22, 21:20

Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy?

Amgen Inc
Webhose 2026 Oct 22, 08:08

Amgen Inc. $AMGN Shares Sold by Foster Victor Wealth Advisors LLC

Amgen Inc
Webhose 2026 Oct 22, 07:53

35,730 Amgen Inc. $AMGN Shares Acquired by Crossmark Global Holdings Inc.

Amgen Inc
Webhose 2026 Oct 22, 07:20

Latin America's Quiet Rise: Argentina and Brazil Enter the Biosimilars Market Spotlight

Amgen Inc
Webhose 2026 Oct 22, 00:00

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

Amgen Inc
Webhose 2026 Oct 21, 17:30

Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?

Amgen Inc
Webhose 2026 Oct 21, 17:12

Sawyer & Company Inc Makes New Investment in Amgen Inc. $AMGN

Amgen Inc
Webhose 2026 Oct 21, 11:04

State Street SPDR Dow Jones (DIA) Sells Goldman Sachs and Caterpillar on Monday

Amgen Inc
Webhose 2026 Oct 21, 09:29

Amgen Inc. $AMGN Stock Holdings Raised by Robeco Institutional Asset Management B.V.

Amgen Inc
Webhose 2026 Oct 21, 08:24

Nisa Investment Advisors LLC Purchases 8,294 Shares of Amgen Inc. $AMGN

Amgen Inc
Webhose 2026 Oct 21, 03:02

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Amgen Inc
Webhose 2026 Oct 21, 01:47

AstraZeneca and Amgen's Tezspire Achieves 69% Remission in Eosinophilic Esophagitis Trial, ETPharma

Amgen Inc
Webhose 2026 Oct 20, 21:00

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)

Amgen Inc
Webhose 2026 Oct 20, 20:51

Dow leads Wall Street higher, investors focus on healthcare stocks

Amgen Inc
Webhose 2026 Oct 20, 18:01

Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors

Amgen Inc
Webhose 2026 Oct 20, 16:55

Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher

Amgen Inc
Webhose 2026 Oct 20, 13:56

AstraZeneca & Amgen's Tezspire Meets Phase 3 Endpoints In Eosinophilic Esophagitis

Amgen Inc
Webhose 2026 Oct 20, 13:01

AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial

Amgen Inc
Webhose 2026 Oct 20, 11:28

Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Amgen Inc
Webhose 2026 Oct 20, 11:00

TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS

Amgen Inc
Webhose 2026 Oct 20, 05:06

Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Buy - Markets Daily

Amgen Inc
Webhose 2026 Oct 19, 23:36

10,773 Amgen Inc. $AMGN Shares Sold by Novem Group

Amgen Inc
Webhose 2026 Oct 19, 23:07

5,750 Shares of Amgen Inc. $AMGN Bought by Greg Jennings LLC - Markets Daily

Amgen Inc
Webhose 2026 Oct 19, 21:39

Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?

Amgen Inc
Webhose 2026 Oct 19, 19:07

Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN - Stock Observer

Amgen Inc
Webhose 2026 Oct 19, 14:07

Amgen Has the Drugs and the Dividend. Now It Needs the Growth

Amgen Inc
Webhose 2026 Oct 19, 13:01

Mattel Appoints Peter Griffith As Chief Financial Officer

Amgen Inc
Webhose 2026 Oct 19, 11:21

2,560 Amgen Inc. $AMGN Shares Sold by Generali Investments Management Co LLC

Amgen Inc
Webhose 2026 Oct 19, 11:13

Amgen Inc. $AMGN Stock Sold by First Bank & Trust

Amgen Inc
Webhose 2026 Oct 19, 11:04

What State Street SPDR Dow Jones (DIA) Bought: Goldman Sachs Leads on Thursday

Amgen Inc
Webhose 2026 Oct 19, 08:58

Comparing Incyte (NASDAQ:INCY) and Amgen (NASDAQ:AMGN) - Stock Observer

Amgen Inc
Webhose 2026 Oct 19, 00:00

Neuroendocrine Carcinoma Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight | ABNewswire

Amgen Inc
Webhose 2026 Oct 18, 23:06

Amgen (NASDAQ:AMGN) Stock Rating Raised to Buy at Wall Street Zen - Daily Political

Amgen Inc
Webhose 2026 Oct 18, 13:44

Investment Analysts' Upgrades for October 18th (AGX, AMGN, AUGO, AVBP, CG, CNM, CVLT, GDS, GLND, HWBK) - Stock Observer

Amgen Inc
Webhose 2026 Oct 18, 09:52

Amgen Inc. $AMGN Position Lifted by IFP Advisors Inc

Amgen Inc
Webhose 2026 Oct 18, 08:08

Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings

Amgen Inc
Webhose 2026 Oct 18, 06:29

Amgen Inc. (NASDAQ:AMGN) Stock Has Average Price Target of $387.93

Amgen Inc
Webhose 2026 Oct 18, 05:06

Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen

Amgen Inc
Webhose 2026 Oct 18, 03:18

Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc. - Daily Political

Amgen Inc
Webhose 2026 Oct 17, 17:26

Amgen Inc. $AMGN Shares Purchased by New England Research & Management Inc. - Zolmax

Amgen Inc
Webhose 2026 Oct 17, 16:48

Amgen Inc. $AMGN Stock Purchased by New England Research & Management Inc.

Amgen Inc
Webhose 2026 Oct 17, 07:53

90,613 Amgen Inc. $AMGN Shares Sold by Fort Washington Investment Advisors Inc. OH

Amgen Inc
Webhose 2026 Oct 17, 07:12

Amgen Inc. $AMGN Shares Acquired by Annex Advisory Services LLC

Amgen Inc
Webhose 2026 Oct 16, 15:36

Amgen (AMGN) Nears Earnings, Is The Stock Pricey?

Amgen Inc
Webhose 2026 Oct 16, 11:04

SPDR Dow Jones Industrial Average ETF (DIA) Sells $31.3 Million More Goldman Sachs on Oct. 14

Amgen Inc
Webhose 2026 Oct 16, 10:00

Amgen Inc. $AMGN Stock Position Reduced by Milestone Asset Management LLC

Amgen Inc
Webhose 2026 Oct 16, 09:57

3,280 Shares of Amgen Inc. $AMGN Bought by Triasima Portfolio Management inc. - Markets Daily

Amgen Inc
Webhose 2026 Oct 16, 08:00

Amgen Inc. $AMGN Stock Holdings Cut by Curated Wealth Partners LLC

Amgen Inc
Webhose 2026 Oct 16, 07:04

Assenagon Asset Management S.A. Acquires 1,344,010 Shares of Amgen Inc. $AMGN

Amgen Inc
Webhose 2026 Oct 16, 05:57

Triasima Portfolio Management inc. Purchases 3,280 Shares of Amgen Inc. $AMGN - Stock Observer

Amgen Inc
Webhose 2026 Oct 16, 04:08

Amgen Inc. $AMGN Stock Sold by Milestone Asset Management LLC - Daily Political

Amgen Inc
Webhose 2026 Oct 16, 02:09

Amgen Inc. $AMGN Stock: Curated Wealth Partners LLC Decreases Holdings - Daily Political

Amgen Inc
Webhose 2026 Oct 16, 00:00

Atherosclerotic Cardiovascular Disease Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight | ABNewswire

Amgen Inc
Webhose 2026 Oct 15, 18:34

Amgen Inc. $AMGN Stake Boosted by State of Alaska Department of Revenue - Zolmax

Amgen Inc
Webhose 2026 Oct 15, 17:29

Amgen Inc. $AMGN Stock Acquired by State of Alaska Department of Revenue

Amgen Inc
Webhose 2026 Oct 15, 17:07

Amgen Inc. $AMGN Stock Sold by WealthPlan Investment Management LLC

Amgen Inc

Amgen news

Latest news

Info

Spread

2.98

Spread (%)

0.6726 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

14:31-20:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

237478019072

Shares Outstanding

540632005

Earnings Date (Next)

1999-11-22

Div Yield

2026-09-11

Ex-Dividend Date

2026-08-21

Forward annual dividend rate

10.08

Forward annual dividend yield

0.0229

EPS

16.1

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Related Instruments

Asset
Sell
Buy
Change (%)

Latest Education Articles

Trustpilot